Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@pharma_indian
indianpharmapost.com > clinical-trials > merck-unveils-early-global-access-plan-for-monthly-hiv-prevention-pill-ahead-of-phase-3-completion-21069

Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion

13+ hour, 27+ min ago   (98+ words) Indian Pharma Post Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion Merck said its strategy combines early generic licensing, regional manufacturing partnerships in Africa and Latin America The Business of Genomics Opportunities, Investments,…...

Google News
indianpharmapost.com > people > sanofi-rejigs-top-leadership-team-as-it-prepares-for-next-strategic-chapter-21072

Sanofi rejigs top leadership team as it prepares for next strategic chapter

14+ hour, 41+ min ago   (103+ words) Indian Pharma Post Sanofi rejigs top leadership team as it prepares for next strategic chapter Sanofi said Emmanuel Frenehard, Head of Digital, and Audrey Duval, Head of Corporate Affairs and President of Sanofi France, will continue reporting directly to Chief…...

@pharma_indian
indianpharmapost.com > news > roche-posts-6-growth-as-pipeline-momentum-accelerates-confirms-2026-outlook-21070

Roche posts 6% growth as pipeline momentum accelerates, confirms 2026 outlook

19+ hour, 27+ min ago   (72+ words) Indian Pharma Post Roche posts 6% growth as pipeline momentum accelerates, confirms 2026 outlook The Business of Genomics Opportunities, Investments, and Innovation in India Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical…...

@pharma_indian
indianpharmapost.com > drug-approval > tsi-receives-turkish-regulatory-authorization-to-initiate-phase-2-prompt-stemi-trial-21067

TSI receives Turkish regulatory authorization to initiate Phase 2 PROMPT-STEMI trial

20+ hour, 7+ min ago   (253+ words) The study is sponsored by TSI Biyoteknoloji ve İlaç A.Ş. (TSI Türkiye), a wholly owned subsidiary of TSI. The authorization permits the study to commence at the clinical centers included in the approved application. "Heart attacks remain a global health…...

@pharma_indian
indianpharmapost.com > news > thermo-fisher-reports-10-revenue-growth-in-q2-raises-fy26-outlook-21065

Thermo Fisher reports 10% revenue growth in Q2, raises FY26 outlook

19+ hour, 34+ min ago   (350+ words) Life sciences giant posts USD 11.99 billion in quarterly revenue, beats analyst estimates and lifts full-year revenue and profit guidance Thermo Fisher Scientific reported Q2 2026 revenue of USD 11.99 billion, up 10% year-on-year from USD 10.85 billion, prompting the company to raise its full-year 2026 revenue…...

Google News
indianpharmapost.com > drug-approval > gsk-wins-fda-approval-for-jideytro-after-nuvalent-acquisition-21064

GSK wins FDA approval for Jideytro after Nuvalent acquisition

22+ hour, 57+ min ago   (340+ words) ROS1-targeted therapy becomes GSK's first marketed lung cancer drug, expanding its oncology portfolio GSK has received US Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a targeted therapy for patients with ROS1-positive non-small cell lung cancer (NSCLC), just days…...

@pharma_indian
indianpharmapost.com > opinion > indian-pharma-manufacturers-are-expanding-healthcare-access-across-emerging-markets-saurabh-agarwal-director-hab-pharma-21059

Indian pharma manufacturers are expanding healthcare access across emerging markets: Saurabh Agarwal, Director, HAB Pharma

23+ hour, 30+ min ago   (63+ words) India did not become the pharmacy of the world by accident and sustaining that position will require continued commitment and long-term investment Saurabh Agarwal, Director, HAB Pharma Dr. Upasana Arora represents India's healthcare sector at Business Forum România–India OneSource…...

@pharma_indian
indianpharmapost.com > news > aurobindo-pharma-signs-voluntary-licensing-pact-with-msd-to-manufacture-alimatravir-21062

Aurobindo Pharma signs voluntary licensing pact with MSD to manufacture alimatravir

23+ hour, 7+ min ago   (328+ words) Royalty-free agreement covers supply of generic HIV prevention drug to 129 low- and middle-income countries, subject to regulatory approvals Aurobindo Pharma Limited has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc., Rahway, New…...

@pharma_indian
indianpharmapost.com > policy > govt-strengthens-ethical-pharma-marketing-framework-under-revised-ucpmp-21053

Govt strengthens ethical pharma marketing framework under revised UCPMP

1+ day, 18+ hour ago   (146+ words) The Department of Pharmaceuticals (DoP) has strengthened the regulatory framework for ethical pharmaceutical marketing through the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024, which was notified on March 12, 2024, replacing the earlier UCPMP, 2015. As per the Minister of State for Chemicals…...

@pharma_indian
indianpharmapost.com > healthcare > apollo-telehealths-keonjhar-digital-dispensary-initiative-crosses-1-million-teleconsultations-21052

Apollo TeleHealth's Keonjhar Digital Dispensary Initiative crosses 1 million teleconsultations

1+ day, 17+ hour ago   (240+ words) Apollo TeleHealth has surpassed one million teleconsultations through its Keonjhar Digital Dispensary Initiative, marking a major milestone in delivering quality primary healthcare to remote tribal, Particularly Vulnerable Tribal Group (PVTG), and mining communities in Odisha. Implemented in partnership with the…...